Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial [Corrigendum].

MLA

Toshida, Hiroshi, et al. “Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial [Corrigendum].” Drug Design, Development & Therapy, vol. 15, Feb. 2021, pp. 813–16. EBSCOhost, https://doi.org/10.2147/DDDT.S301482.

APA

Toshida, H., Funaki, T., Ono, K., Tabuchi, N., Watanabe, S., Seki, T., Otake, H., Kato, T., Ebihara, N., & Murakami, A. (2021). Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial [Corrigendum]. Drug Design, Development & Therapy, 15, 813–816. https://doi.org/10.2147/DDDT.S301482

Chicago

Toshida, Hiroshi, Toshinari Funaki, Koichi Ono, Nobuhito Tabuchi, Sota Watanabe, Tamotsu Seki, Hiroshi Otake, Takuji Kato, Nobuyuki Ebihara, and Akira Murakami. 2021. “Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial [Corrigendum].” Drug Design, Development & Therapy 15 (February): 813–16. doi:10.2147/DDDT.S301482.